RCEL
AVITA Medical·NASDAQ
--
--(--)
--
--(--)
7.55 / 10
Outperform
Sentiment is strong (7.55/10) and fund‑flow score 7.63, with positive inflow ratios despite negative trends. Analysts issue one Strong Buy and one Buy, though one has a 0% win rate. Price is down 17%, suggesting caution.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Carl ByrnesBuy
Date2026-03-05
InstitutionNorthland Capital Markets
Times predicted1
Historical Win Rate0.0%
Jason KolbertStrong Buy
Is money flowing into or out of RCEL?
- RCEL holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.55/10 (Outperform).
